• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS - 3; NIP

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE VIABAHN® ENDOPROSTHESIS - 3; NIP Back to Search Results
Device Problem Improper or Incorrect Procedure or Method (2017)
Patient Problem Embolism (1829)
Event Date 02/20/2018
Event Type  Injury  
Manufacturer Narrative
No lot number information was supplied; therefore, no review of the manufacturing paperwork could be performed.The device was not returned.Therefore, direct product analysis was not possible.Instructions for use for gore® viabahn® endoprosthesis states in the intended use / indications section: the gore® viabahn® endoprosthesis is indicated for improving blood flow in patients with symptomatic peripheral arterial disease in superficial femoral artery lesions with reference vessel diameters ranging from 4.0 ¿ 7.5 mm.The gore® viabahn® endoprosthesis is indicated for improving blood flow in patients with symptomatic peripheral arterial disease in iliac artery lesions with reference vessel diameters ranging from 4.0 ¿ 12 mm.Warnings section state: w.L.Gore & associates has insufficient clinical and experimental data upon which to base any conclusions regarding the effectiveness of the gore.
 
Event Description
The following abstract was reviewed: ruptured extracranial carotid artery: endovascular treatment with covered stent graft.Since january 2009, eight patients with extracranial carotid artery rupture received endovascular treatment with covered stent graft.The patient records and radiologic findings were reviewed retrospectively.Technical success and immediate hemostasis were achieved in all cases.Gore® viabahn® endoprostheses were used in four of the eight patients.One patient presented with neck swelling and pain.Ruptured site was in common carotid artery (cca) and cause of injury was listed as spontaneous.Ct findings showed hematoma and pseudo-aneurysm (pa); dsa findings show pa of left distal cca.Angiography after deployment revealed atherosclerotic stenosis in the cervical segment of the internal carotid artery (ica).It was reported the patient experienced postoperative complications.One the second day mri, the patient presented minor stroke in the ipsilateral cerebrum.However, the patient fully recovered from the neurological symptoms during follow-up periods.No intervention was reported.Further information was requested but not made available.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE VIABAHN® ENDOPROSTHESIS - 3
Type of Device
NIP
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
Manufacturer (Section G)
MEDICAL ECHO RIDGE B/P
3250 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
genevieve begay
1500 n. 4th street
9285263030
MDR Report Key8157830
MDR Text Key130307778
Report Number2017233-2018-00761
Device Sequence Number1
Product Code PFV
Combination Product (y/n)N
Reporter Country CodeKS
PMA/PMN Number
P040037
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Reporter Occupation Physician
Type of Report Initial
Report Date 11/19/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/12/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age69 YR
-
-